Best Drug Discovery Software - Page 11

Signals One

Powered by industry-leading ChemDraw® and Spotfire™, the Signals One delivers best-in-class analysis and data visualization for the Make-Test-Decide R&D life cycle, fostering rapid innovation in Pharma & Biotech and Chemicals & Materials. In Pharma & Biotech, the Suite is ideally suited for research use cases involving early and late-stage in vitro assays, cell line optimization, biologics process optimization, in vitro DMPK assays, animal pharmacokinetics studies, efficacy, and safety studies. And in Chemicals & Materials, the Suite empowers product development workflows by increasing productivity, helps to improve product performance by simplifying screening and optimization processes, and reduces product development timelines.

Signet Therapeutics

Signet Therapeutics is a clinical-stage biotechnology company pioneering the development of first-in-class targeted cancer therapies by integrating organoid disease models with artificial intelligence (AI). Their innovative approach accelerates drug discovery and enhances the precision of treatments, particularly for cancers that are unresponsive to conventional therapies. Key Features and Functionality: - Organoid Disease Models: Utilizes three-dimensional organoid models derived from patient genomics to closely mimic human biology, enabling accurate evaluation of drug efficacy and identification of novel therapeutic targets. - AI-Driven Drug Discovery: Employs AI and robotics to streamline the identification, design, and optimization of small-molecule compounds, significantly reducing the time from target discovery to clinical trials. - Innovative Drug Pipeline: Developed SIGX1094, the world's first targeted therapy for diffuse gastric cancer (DGC), which has received FDA Orphan Drug Designation and Fast Track Designation, and is currently in Phase I clinical trials. - Collaborative Platform: Offers its organoid platform for external collaborations, providing preclinical drug discovery and development services to biotech and pharmaceutical partners. Primary Value and Solutions: Signet Therapeutics addresses the critical need for effective treatments in aggressive and treatment-resistant cancers. By combining organoid models with AI, they enhance the predictability and efficiency of drug development, leading to faster clinical advancements and potentially higher success rates. Their approach not only accelerates the discovery of novel therapies but also offers hope to patients with limited treatment options, particularly those suffering from cancers like diffuse gastric cancer.

SILCS

SILCS employs multiple small molecule probes with various functional groups, explicit solvent modeling and target molecule flexibility to perform rigorous free energy calculations.

Solix EAI Pharma

Solix EAI Pharma is an AI-powered enterprise platform designed for pharmaceutical and biotech organizations to accelerate drug discovery and development. It provides a unified, governed and AI-ready data foundation that brings together scientific, clinical, experimental and historical data. The platform combines data management, AI and ML predictive models, explainable AI, semantic intelligence and automation to help researchers generate faster insights, improve decision-making and reduce drug development timelines and costs. Solix EAI Pharma also provides built-in security, governance, data lineage and compliance capabilities for regulated life sciences environments.

SpendView

THE RIGHT PLATFORMS AND PEOPLE IN LIFE SCIENCES Founded more than a decade ago by experts in life sciences and biopharma, Vector Health is a leading provider of technology and service solutions in the life sciences industry for: Speaker bureau management Aggregate spend compliance management Commercialization strategies Thought leadership to guide clients through an ever evolving landscape. With a deep understanding of your goals, culture and systems, we tailor event management and aggregate spend solutions to your specific needs. This helps your company achieve sales goals through compliant interactions with healthcare professionals. Count on Vector Health for in-depth experience in: Anti-infectives Allergy and asthma Analgesics CNS Dermatology Hepatology Hypertension Oncology Macular degeneration Multiple sclerosis Neurology Rheumatoid arthritis Animal health

SpliceCore

SpliceCore is a dedicated AI platform for RNA therapeutics discovery. We developed this technology platform specifically for the analysis of RNA sequencing data.

Standigm

StarDrop

With its comprehensive suite of integrated software, StarDrop™ delivers best-in-class in silico technologies within a highly visual and user-friendly interface. StarDrop™ enables a seamless flow from the latest data through predictive modelling to decision-making regarding the next round of synthesis and research, improving the speed, efficiency, and productivity of the discovery process.

Structure Elucidator

Elucidate complex structures from experimental data with the help of expert algorithms

SYNTHIA Retrosynthesis Software

SYNTHIA Retrosynthesis Software is a cloud-based, software-as-a-service (SaaS) platform that helps chemists rapidly design robust synthetic routes using expert-coded rules curated by chemists and engineered by computer scientists, enabling discovery of novel pathways for both new and published target molecules; the technology has been developed over 21 years and searches a catalog of more than 12 million commercially available starting materials and building blocks. It is purpose-built for computer-aided synthesis design (CASD/CASP), accelerating route scouting while improving speed, safety, and cost efficiency across discovery and development workflows. Scientists can run Automatic, Step-by-Step, Similar Molecules, or Shared Path Library analyses, then view up to 50 synthetic pathways per target and filter results by number of steps, pathway similarity, starting-material cost, and protecting-group use; each pathway includes typical reaction conditions, illustrative publications, and options to export or share for collaboration. Users can tailor searches with preset or custom configurations to include preferred reactions, exclude reagents or classes, set price limits, and start from commercial or in-house inventories—streamlining from target input to shopping list generation of buyable building blocks. SYNTHIA supports greener route design by allowing users to avoid hazardous reagents and seek safer alternatives as part of configurable search criteria. For integration at scale, the SYNTHIA API offers two modalities: the Full Retro API returns detailed pathway data (reaction SMILES and names, literature references, prices and CAS numbers of starting materials, and pathway scores), while the Synthetic Accessibility Score (SAS) API provides a 0–10 complexity score to triage large virtual libraries; both are designed to plug into KNIME, Pipeline Pilot, Jupyter, and similar workflows. The platform runs on an ISO 27001–certified secure cloud infrastructure, supporting enterprise-grade data protection for cheminformatics workflows. Across medicinal, discovery, and process chemistry teams, SYNTHIA is used to save time, reduce costs, and expand idea space by proposing alternative, often more atom-efficient disconnections and ranked pathways that complement literature precedent and in-house expertise. Access options include a free individual trial and tiered licenses (including batch analysis and custom inventory features for advanced needs), making it easy to pilot the software and scale with project demand.

Tahoe Therapeutics

Tahoe Therapeutics is a biotechnology company that develops AI models of human cells to enhance drug discovery.

TandemAI (TandemViz)

Target Informatics Platform (TIP)

Eidogen-Sertanty's Target Informatics Platform (TIP) is the world's first structural informatics system and knowledgebase that enables researchers with the ability to interrogate the druggable genome from a structural perspective.

Tempus

Torx DMTA

Torx is a visual, chemistry aware, web-based platform that inspires discovery chemistry teams to work together and deliver faster. Dedicated stand-alone modules for Design, Make, Test and Analyze work in synergy to deliver a complete discovery DMTA cycle platform enabling chemists to design molecules faster, capture and share knowledge, and manage resources with ease.